Dr. Zach Adelman's lab at Texas A&M Agrilife Research focuses on innovative genetic engineering strategies to control mosquito populations that transmit diseases like dengue, yellow fever, and chikungunya. The lab explores how gene editing tools like CRISPR can be used to insert or remove genes from mosquitoes, improving efforts to develop safer and more effective mosquito control methods. Their research has the potential to significantly impact public health by making gene drive technologies more reliable and manageable.

Dr. Julian G. Hurdle's lab focuses on understanding the increasing resistance of Clostridium difficile to antibiotics, particularly vancomycin. Their research aims to uncover the genetic changes in these bacteria that lead to treatment failures in patients. The lab uses clinical studies and genetic analyses to improve treatment strategies and ultimately contribute to better health outcomes for patients suffering from C. difficile infections.

Dr. Reza Avazmohammadi's lab focuses on understanding heart function, especially how the heart's ventricles relax and adapt under different conditions. They explore the mechanics behind heart diseases like heart failure and pulmonary hypertension by using advanced imaging and deep learning techniques. The goal is to identify ways to treat these conditions more effectively by examining both passive and active changes in heart tissue.

Dr. Ivan Rusyn's lab at Texas A&M focuses on improving how we assess the safety of chemicals without relying on animal testing. Their work involves creating advanced laboratory models and computer simulations, which can predict the effects of chemicals more accurately. By developing these new methodologies, the lab aims to enhance regulatory decision-making and promote public health.

Dr. Deborah Bell-Pedersen's lab at Texas A&M University focuses on understanding how the circadian clock affects the production of proteins within cells. They study the complex mechanisms that control when and how proteins are made, particularly through a model organism called Neurospora crassa. Their research aims to reveal how these daily rhythms in protein synthesis impact health, metabolism, and drug effectiveness, potentially leading to better treatments for various diseases.

In Dr. Stephen H. Safe's lab at Texas A&M University, researchers focus on developing new treatments for colorectal cancer. They study a specific receptor, NR4A1, which is found in high levels in colon cancer patients and is linked to tumor growth and immune system suppression. By using innovative compounds known as CDIMs, the team aims to create drugs that can both fight cancer and help improve the immune response against tumors.

Professor A. Joshua Wand's lab at Texas A&M Agrilife Research focuses on understanding how proteins work and how their structures affect their functions in health and diseases. The lab studies the impact of entropy, a measure of disorder, on the stability and function of proteins, particularly in the context of diseases like Parkinson's. By exploring these relationships, the lab aims to uncover new pathways for disease intervention and develop strategies to address various health issues related to protein dysfunction.

Dr. Yun Huang's lab at Texas A&M University focuses on understanding how epigenetic factors regulate heart development. The team investigates how specific genetic mutations and maternal diet can impact heart formation and contribute to congenital heart diseases. They use cutting-edge techniques with genetically modified mouse models and human stem cells to explore these mechanisms and seek ways to improve heart development and health.

Dr. Fadi Khasawneh's lab at Texas A&M University focuses on understanding how the exposure of future fathers to electronic nicotine delivery systems (like e-cigarettes) impacts cardiovascular health and thrombosis, especially in offspring. Their research aims to uncover the mechanisms behind these effects, including how paternal exposure influences platelet function and blood clotting. By investigating these areas, the lab seeks to inform public health strategies and policies related to tobacco use and paternal health.

Dr. Roderick H. Dashwood's lab focuses on cancer research, specifically targeting immune responses in patients with Familial Adenomatous Polyposis (FAP), a genetic condition that increases the risk of colorectal cancer. The lab investigates how certain drugs can upregulate the Major Histocompatibility Complex (MHC) on cancer cells to enhance the immune system's ability to recognize and attack tumors. By combining traditional cancer drugs with new epigenetic therapies, they aim to improve immune responses before cancer develops, thereby offering new interventions for at-risk patients.

Dr. Arthur D. Laganowsky's lab focuses on understanding how lipids interact with membrane proteins, which are essential for many biological processes. They study the complex relationships between lipids and proteins to reveal how lipids can influence the behavior and function of these proteins within cell membranes. By using advanced techniques like mass spectrometry and lipidomics, the lab aims to uncover insights that can improve our understanding of cell biology and membrane function.

Dr. Zhenyu Li's lab focuses on understanding the role of B-type natriuretic peptide (BNP) not just as a biomarker for cardiovascular diseases like heart failure, but also as an active participant in the development of these conditions. The research investigates how BNP contributes to thrombosis, a critical factor in cardiovascular events, by affecting platelet function. The ultimate goal is to reveal new therapeutic targets that can improve heart disease prognosis.

Dr. Wenshe Ray Liu's lab at Texas A&M University focuses on innovative methods for studying proteins, particularly how they are modified after being made. By using a special technique that incorporates noncanonical amino acids into proteins, the lab explores important biological questions related to cell regulation and response to disease. Their research aims to identify how specific modifications to proteins can influence various cellular processes, potentially leading to new therapeutic strategies.

Dr. Doodipala Samba Reddy's lab focuses on developing innovative treatments to counteract the harmful effects of nerve agents, particularly in the context of seizure management and brain protection. The primary research involves creating new hydrophilic neurosteroids that can effectively treat severe seizures that do not respond to current medications like midazolam. This research is particularly relevant for military and civilian safety during chemical warfare scenarios.

Dr. Melissa Grunlan's lab focuses on developing innovative treatments for osteochondral defects, which involve damage to cartilage and bone in joints. They aim to create a bioprosthetic implant that combines a synthetic cartilage cap with a biodegradable bone scaffold to enhance healing and restore joint function. This research is critical for improving patient outcomes in those suffering from joint pain and osteoarthritis.

Dr. Michael C. Golding's lab focuses on understanding how paternal alcohol use can influence the health and development of offspring. Specifically, they explore how alcohol consumption by fathers can lead to epigenetic changes that affect mitochondrial function and contribute to fetal alcohol spectrum disorders (FASDs). By studying these changes in transgenic mouse models, the lab aims to uncover the genetic and biological mechanisms behind these effects and how they can impact long-term health outcomes for children.

Dr. Mansoor A Khan's lab focuses on improving medication delivery systems for pediatric patients, particularly in the treatment of HIV and toxoplasmosis. By utilizing advanced 3D printing techniques, the lab aims to create flexible dosage forms that are tailored to children's needs, addressing critical gaps in current medication formulations. This innovative approach seeks to enhance patient adherence to therapy by providing age-appropriate and effective delivery systems.

Dr. Weston W. Porter's lab at Texas A&M is focused on understanding how biological clocks affect various cellular processes, particularly in the mammary gland. The research explores how disruptions to circadian rhythms can lead to significant health issues, including metabolic disorders and cancer. By investigating the roles of specific factors like PER2, the lab aims to uncover the molecular mechanisms that underlie cell differentiation and homeostasis.

Dr. James C. Sacchettini's lab focuses on improving tuberculosis treatment by exploring the mycobacterial cell wall, which is crucial for the bacteria's survival. The team investigates how to make existing antibiotics more effective by understanding and exploiting synergies between different drugs. Their ultimate goal is to develop new combination therapies that can overcome drug resistance and accelerate TB treatment.

Dr. Jon T Skare's lab focuses on Lyme disease, specifically how the bacterium Borrelia burgdorferi, which causes the disease, establishes and maintains infections. The research investigates a regulatory protein called BosR that helps the bacteria adapt to different environments during infection. By understanding BosR's role in regulating gene expression, the lab aims to uncover new strategies for preventing and treating Lyme disease.